Literature DB >> 24046809

Molecular epidemiology of selected sexually transmitted infections.

Hamid Jalal1, Andrew Delaney, Neil Bentley, Christopher Sonnex, Christopher A Carne.   

Abstract

Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) are established pathogens for human genital tract. However, the role of Ureaplasma urealyticum (UU) and Ureaplasma parvum (UP) in genital pathology is poorly unerstood. A prospective study to investigate the prevalence of above infections was performed on a cohort of 1,718 consecutive patients attending a Genitourinary Medicine (GUM) clinic. A previously published in-house real-time PCR assay, for the detection of CT DNA in genital swabs, was modified for this study. Two amplification reactions detected the DNAs of TV, NG, MG, CT, UU and UP in genital swabs from 4 (0.2%), 11 (0.6%), 17 (1%), 129 (8%), 282 (16%) and 636 (37%) patients, respectively. 594 (70%) of 848 women and 333 (38%) of 870 men were infected with at least one type of microorganism. Among 594 infected females, 485 (82%) had a single infection, 97 (16%) had a double infection, and 12 (2%) had a triple infection. Of the 333 infected men, 304 (91%) had a single infection, 27 (8%) had a double infection, and 2 (1%) had a triple infection. The prevalence of infection in both genders decreased with increasing age. The prevalence proportion of UP was significantly higher in women (54%) compared with men (18%). The high prevalence of UU and UP suggests that these bacteria are commensals of genital tract.

Entities:  

Keywords:  Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae; PCR; Trichomonas vaginalis; Ureaplasma parvum; Ureaplasma urealyticu; epidemiology

Year:  2013        PMID: 24046809      PMCID: PMC3773568     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  18 in total

1.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.

Authors:  M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

2.  Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis.

Authors:  João P Gomes; Maria J Borrego; Berna Atik; Irene Santo; Jacinta Azevedo; Armando Brito de Sá; Paulo Nogueira; Deborah Dean
Journal:  Microbes Infect       Date:  2005-07-13       Impact factor: 2.700

3.  The prevalence of urogenital micro-organisms detected by a multiplex PCR-reverse line blot assay in women attending three sexual health clinics in Sydney, Australia.

Authors:  Michelle L McKechnie; Richard J Hillman; Rachel Jones; Penelope C Lowe; Deborah L Couldwell; Stephen C Davies; Fiona King; Fanrong Kong; Gwendolyn L Gilbert
Journal:  J Med Microbiol       Date:  2011-03-17       Impact factor: 2.472

4.  Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples.

Authors:  M M Rodrigues; P Á Fernandes; J P Haddad; M C Paiva; M Do Carmo M Souza; T C A Andrade; A P Fernandes
Journal:  J Obstet Gynaecol       Date:  2011       Impact factor: 1.246

Review 5.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic.

Authors:  Jørgen Skov Jensen; Eva Björnelius; Birthe Dohn; Peter Lidbrink
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Prevalence, clinical features and quantification of genital non-viral infections.

Authors:  C A Carne; J Gibbs; A Delaney; C Sonnex; N Q Verlander; A Smielewska; E Skeggs; N Bentley; H Jalal
Journal:  Int J STD AIDS       Date:  2013-04       Impact factor: 1.359

8.  Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study.

Authors:  Pippa Oakeshott; Adamma Aghaizu; Phillip Hay; Fiona Reid; Sally Kerry; Helen Atherton; Ian Simms; David Taylor-Robinson; Birthe Dohn; Jorgen S Jensen
Journal:  Clin Infect Dis       Date:  2010-10-13       Impact factor: 9.079

9.  Frequency of Chlamydia trachomatis in Ureaplasma-positive healthy women attending their first prenatal visit in a community hospital in Sapporo, Japan.

Authors:  Tomohiro Yamazaki; Megumi Matsumoto; Junji Matsuo; Kiyotaka Abe; Kunihiro Minami; Hiroyuki Yamaguchi
Journal:  BMC Infect Dis       Date:  2012-04-02       Impact factor: 3.090

10.  Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs.

Authors:  A M Caliendo; J A Jordan; A M Green; J Ingersoll; R J Diclemente; G M Wingood
Journal:  Infect Dis Obstet Gynecol       Date:  2005-09
View more
  3 in total

Review 1.  Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis.

Authors:  Lukas Baumann; Manuel Cina; Dianne Egli-Gany; Myrofora Goutaki; Florian S Halbeisen; Gian-Reto Lohrer; Hammad Ali; Pippa Scott; Nicola Low
Journal:  Sex Transm Infect       Date:  2018-02-09       Impact factor: 3.519

2.  Cervical cytopathological findings in Korean women with Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum infections.

Authors:  Yuri Choi; Jaesook Roh
Journal:  ScientificWorldJournal       Date:  2014-01-08

3.  Molecular detection of Chlamydia trachomatis and other sexually transmitted bacteria in semen of male partners of infertile couples in Tunisia: the effect on semen parameters and spermatozoa apoptosis markers.

Authors:  Hanen Sellami; Abir Znazen; Afifa Sellami; Hela Mnif; Nour Louati; Soumaya Ben Zarrouk; Leila Keskes; Tarek Rebai; Radhouane Gdoura; Adnene Hammami
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.